U.S. Drug Discovery Outsourcing Market Size & Outlook
Related Markets
U.S. drug discovery outsourcing market highlights
- The U.S. drug discovery outsourcing market generated a revenue of USD 2,696.6 million in 2025 and is expected to reach USD 5,582.5 million by 2033.
- The U.S. market is expected to grow at a CAGR of 9.7% from 2026 to 2033.
- In terms of segment, lead identification & candidate optimization was the largest revenue generating workflow in 2025.
- Other Associated Workflow is the most lucrative workflow segment registering the fastest growth during the forecast period.
Drug discovery outsourcing market data book summary
| Market revenue in 2025 | USD 2,696.6 million |
| Market revenue in 2033 | USD 5,582.5 million |
| Growth rate | 9.7% (CAGR from 2026 to 2033) |
| Largest segment | Lead identification & candidate optimization |
| Fastest growing segment | Other Associated Workflow |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Target Identification & Screening, Target Validation & Functional Informatics, Lead Identification & Candidate Optimization, Preclinical Development, Other Associated Workflow |
| Key market players worldwide | Albany Molecular Research, Evotec SE, Labcorp Holdings Inc, GenScript ProBio, Pharmaceutical Product Development, Charles River Laboratories International Inc, Wuxi AppTec Co Ltd, Merck & Co Inc, Thermo Fisher Scientific Inc, Dalton Pharma Services, Jubilant Biosys, Qiagen NV, Eurofins Scientific SE, Dr. Reddy’s Laboratories, Pharmaron Beijing Co Ltd Ordinary Shares - Class H, TCG Lifesciences, Syngene, Oncodesign, DiscoveRX, Domainex |
Other key industry trends
- In terms of revenue, U.S. accounted for 33.4% of the global drug discovery outsourcing market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In North America, U.S. drug discovery outsourcing market is projected to lead the regional market in terms of revenue in 2033.
- Canada is the fastest growing regional market in North America and is projected to reach USD 1,020.6 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Drug Discovery Outsourcing Market Scope
Drug Discovery Outsourcing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Domainex | View profile | 11-50 | Cambridge, Cambridgeshire, United Kingdom, Europe | http://www.domainex.co.uk |
| DiscoveRX | View profile | 51-100 | Fremont, Missouri, United States, North America | http://www.discoverx.com |
| Oncodesign | View profile | 101-250 | Dijon, Bourgogne, France, Europe | http://www.oncodesign.com |
| Syngene | View profile | 1001-5000 | Bangalore, Karnataka, India, Asia | http://www.syngeneintl.com |
| TCG Lifesciences | View profile | 501-1000 | Kolkata, West Bengal, India, Asia | http://www.tcgls.com/ |
| Dalton Pharma Services | View profile | 51-100 | Toronto, Ontario, Canada, North America | https://www.dalton.com/ |
| Pharmaceutical Product Development | View profile | 10001+ | Wilmington, North Carolina, United States, North America | https://ppd.com |
| Albany Molecular Research | View profile | 1001-5000 | Albany, New York, United States, North America | http://amriglobal.com |
| Jubilant Biosys | View profile | 501-1000 | Bengaluru, Karnataka, India, Asia | https://www.jubilantbiosys.com/ |
| Pharmaron Beijing Co Ltd Ordinary Shares - Class H | View profile | 20295 | No. 248 Queen’s Road East, 40th Floor, Dah Sing Financial Centre, Wanchai, Hong Kong, Hong Kong | https://www.pharmaron.com |
| GenScript ProBio | View profile | 1001-5000 | Nanjing, Jiangsu, China, Asia | https://www.genscriptprobio.cn |
| Evotec SE | View profile | 5055 | Essener Bogen 7, Manfred Eigen Campus, Hamburg, Germany, 22419 | https://www.evotec.com |
| Wuxi AppTec Co Ltd | View profile | 41116 | 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai, China, People's Republic of, 200131 | https://www.wuxiapptec.com |
| Dr. Reddy’s Laboratories | View profile | 10001+ | Hyderabad, Andhra Pradesh, India, Asia | http://www.drreddys.com/ |
| Labcorp Holdings Inc | View profile | 67000 | 358 South Main Street, Burlington, NC, United States, 27215 | https://www.labcorp.com |
| Merck & Co Inc | View profile | 72000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | https://www.merck.com |
| Charles River Laboratories International Inc | View profile | 21400 | 251 Ballardvale Street, Wilmington, MA, United States, 01887 | https://www.criver.com |
| Eurofins Scientific SE | View profile | 61798 | 23 Val Fleuri, Luxembourg, Luxembourg, L-1526 | https://www.eurofins.com |
| Qiagen NV | View profile | 5900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | https://www.qiagen.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
U.S. drug discovery outsourcing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug discovery outsourcing market will help companies and investors design strategic landscapes.
Lead identification & candidate optimization was the largest segment with a revenue share of 35.56% in 2025. Horizon Databook has segmented the U.S. drug discovery outsourcing market based on target identification & screening, target validation & functional informatics, lead identification & candidate optimization, preclinical development, other associated workflow covering the revenue growth of each sub-segment from 2021 to 2033.
U.S. is amongst the key markets in the international pharmaceutical industry and is responsible for around 80% of global pharmaceutical sales. Major factors such as developed infrastructure, increase in R&D investment, and rise in incidence of various diseases are driving the growth of drug discovery outsourcing market in the U.S.
In addition, public-private partnerships formed with the aim of developing novel drug molecules are expected to dramatically impact market growth in this region. For instance, Pfizer, Inc, has created many Centers for Therapeutic Innovations (CTI) in the U.S.
This company joined hands with 21 academic medical centers in the U.S. If the challenges faced in coordination are handled properly, strategic alliances can improve the competitive advantage of pharmaceutical enterprises and enhance public welfare by discovering and developing new drugs.
Reasons to subscribe to U.S. drug discovery outsourcing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. drug discovery outsourcing market databook
-
Our clientele includes a mix of drug discovery outsourcing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. drug discovery outsourcing market , including forecasts for subscribers. This country databook contains high-level insights into U.S. drug discovery outsourcing market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
US Workflow - Drug Discovery Outsourcing Market size, 2025 - 2033 (US$M)
U.S. Drug Discovery Outsourcing Market Outlook Share, 2025 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
